Genscript Biotech Corp (STU:G51)

Half Year 2025 Genscript Biotech Corp Earnings Call Transcript

Aug 17, 2025 / 11:15 PM GMT

Transcript

Key Points

Positve

Genscript Biotech Corp (GNNSF) reported an impressive 82% year-over-year revenue growth in the first half of 2025.
The company's adjusted profit from continuing operations significantly increased to approximately $180 million.
The industrial synthetic biology segment continued its industry-leading growth trajectory.
Genscript Biotech Corp (GNNSF) achieved significant breakthroughs in ESG ratings, including a silver medal from EcoVadis and an MSCI ESG rating upgrade to AA.
The company has a strong cash position of $970 million, supporting global expansion, R&D progress, and capacity ramp-up.

Negative

The net loss for the group was about $24.5 million, although this was significantly narrowed compared to the previous year.
The loss was largely affected by non-operational foreign exchange gains and losses.
The gross margin has been temporarily impacted by a change in product mix and global capacity expansion.
The company faced challenges in the CGT CDMO segment, with strong price competition affecting growth.
There is uncertainty regarding future milestone payments from the Lenovo collaboration due to ongoing clinical trials.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

1548.HK - Genscript Biotech Corp
Half Year 2025 Genscript Biotech Corp Earnings Call
Aug 17, 2025 / 11:15PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hey and thank you for standing by. Welcome to JanScript Biotech 2025 interim results conference call.

At this time, all participants are a listen-only mode.

After the speaker's presentation, there will be a question and answer session.

To ask a question during the session, you need to press one and one on your telephone keypad.

You will then hear an automated message advising your hand is raised.

To withdraw your question, please press one and one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, CFO Josie Zhao. Please go ahead.

------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.